Cargando…

Topical application of platelet-rich plasma for diabetic foot ulcers: A systematic review

AIM: To determine if topical application of platelet-rich plasma (PRP) to diabetic foot ulcers (DFUs) results in superior healing rates. METHODS: A systematic review was registered with PROSPERO and performed using PRISMA guidelines. Level I-IV investigations of topical PRP application in DFUs were...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirase, Takashi, Ruff, Eric, Surani, Salim, Ratnani, Iqbal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198285/
https://www.ncbi.nlm.nih.gov/pubmed/30364787
http://dx.doi.org/10.4239/wjd.v9.i10.172
_version_ 1783364938494902272
author Hirase, Takashi
Ruff, Eric
Surani, Salim
Ratnani, Iqbal
author_facet Hirase, Takashi
Ruff, Eric
Surani, Salim
Ratnani, Iqbal
author_sort Hirase, Takashi
collection PubMed
description AIM: To determine if topical application of platelet-rich plasma (PRP) to diabetic foot ulcers (DFUs) results in superior healing rates. METHODS: A systematic review was registered with PROSPERO and performed using PRISMA guidelines. Level I-IV investigations of topical PRP application in DFUs were sought in multiple databases including: MEDLINE, Web of Science, and Cochrane Central Register of Controlled Trials. The search terms used were “platelet rich plasma”, “diabetes”, “ulcers”, and “wound”. The Modified Coleman Methodology Score (MCMS) was used to analyze study methodological quality. Study heterogeneity and a mostly non-comparative nature of evidence precluded meta-analysis. Only the outcome measurements used by more than 50% of the studies were included in the data synthesis to increase power of the measurement over that of individual studies. A weighted mean of healing rate per week between PRP group vs controls were compared using two-sample z-tests using P-value of less than 0.05 for significance. RESULTS: One thousand two hundred and seventeen articles were screened. Eleven articles (322 PRP subjects, 126 controls, PRP subject mean age 58.4 ± 7.2 years, control mean age 58.7 ± 5.9 years) were analyzed. Six articles were level II evidence, four were level III, and one article was level IV. The mean MCMS was 61.8 ± 7.3. Healing rate was significantly faster with PRP application compared to controls (0.68 ± 0.56 cm(2)/wk vs 0.39 ± 0.09 cm(2)/wk; P < 0.001). Mean heal time to > 90% of the original ulcer area was 7.8 ± 2.7 wk and 8.3 ± 3.7 wk for patients in the PRP group and control groups, respectively (P = 0.115). There were significantly lower adverse effects reported with PRP application compared to controls (7 wound infections, 1 contact dermatitis vs 14 wound infections, 1 maceration; P < 0.001). CONCLUSION: The topical application of PRP for DFUs results in statistically superior healing rates and lower complication rates compared to controls.
format Online
Article
Text
id pubmed-6198285
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-61982852018-10-24 Topical application of platelet-rich plasma for diabetic foot ulcers: A systematic review Hirase, Takashi Ruff, Eric Surani, Salim Ratnani, Iqbal World J Diabetes Systematic Reviews AIM: To determine if topical application of platelet-rich plasma (PRP) to diabetic foot ulcers (DFUs) results in superior healing rates. METHODS: A systematic review was registered with PROSPERO and performed using PRISMA guidelines. Level I-IV investigations of topical PRP application in DFUs were sought in multiple databases including: MEDLINE, Web of Science, and Cochrane Central Register of Controlled Trials. The search terms used were “platelet rich plasma”, “diabetes”, “ulcers”, and “wound”. The Modified Coleman Methodology Score (MCMS) was used to analyze study methodological quality. Study heterogeneity and a mostly non-comparative nature of evidence precluded meta-analysis. Only the outcome measurements used by more than 50% of the studies were included in the data synthesis to increase power of the measurement over that of individual studies. A weighted mean of healing rate per week between PRP group vs controls were compared using two-sample z-tests using P-value of less than 0.05 for significance. RESULTS: One thousand two hundred and seventeen articles were screened. Eleven articles (322 PRP subjects, 126 controls, PRP subject mean age 58.4 ± 7.2 years, control mean age 58.7 ± 5.9 years) were analyzed. Six articles were level II evidence, four were level III, and one article was level IV. The mean MCMS was 61.8 ± 7.3. Healing rate was significantly faster with PRP application compared to controls (0.68 ± 0.56 cm(2)/wk vs 0.39 ± 0.09 cm(2)/wk; P < 0.001). Mean heal time to > 90% of the original ulcer area was 7.8 ± 2.7 wk and 8.3 ± 3.7 wk for patients in the PRP group and control groups, respectively (P = 0.115). There were significantly lower adverse effects reported with PRP application compared to controls (7 wound infections, 1 contact dermatitis vs 14 wound infections, 1 maceration; P < 0.001). CONCLUSION: The topical application of PRP for DFUs results in statistically superior healing rates and lower complication rates compared to controls. Baishideng Publishing Group Inc 2018-10-15 2018-10-15 /pmc/articles/PMC6198285/ /pubmed/30364787 http://dx.doi.org/10.4239/wjd.v9.i10.172 Text en ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Systematic Reviews
Hirase, Takashi
Ruff, Eric
Surani, Salim
Ratnani, Iqbal
Topical application of platelet-rich plasma for diabetic foot ulcers: A systematic review
title Topical application of platelet-rich plasma for diabetic foot ulcers: A systematic review
title_full Topical application of platelet-rich plasma for diabetic foot ulcers: A systematic review
title_fullStr Topical application of platelet-rich plasma for diabetic foot ulcers: A systematic review
title_full_unstemmed Topical application of platelet-rich plasma for diabetic foot ulcers: A systematic review
title_short Topical application of platelet-rich plasma for diabetic foot ulcers: A systematic review
title_sort topical application of platelet-rich plasma for diabetic foot ulcers: a systematic review
topic Systematic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198285/
https://www.ncbi.nlm.nih.gov/pubmed/30364787
http://dx.doi.org/10.4239/wjd.v9.i10.172
work_keys_str_mv AT hirasetakashi topicalapplicationofplateletrichplasmafordiabeticfootulcersasystematicreview
AT rufferic topicalapplicationofplateletrichplasmafordiabeticfootulcersasystematicreview
AT suranisalim topicalapplicationofplateletrichplasmafordiabeticfootulcersasystematicreview
AT ratnaniiqbal topicalapplicationofplateletrichplasmafordiabeticfootulcersasystematicreview